Lenzing Future Growth
Future criteria checks 3/6
Lenzing is forecast to grow earnings and revenue by 106.7% and 2.8% per annum respectively. EPS is expected to grow by 107.7% per annum. Return on equity is forecast to be 5.7% in 3 years.
Key information
106.7%
Earnings growth rate
107.7%
EPS growth rate
Chemicals earnings growth | 28.3% |
Revenue growth rate | 2.8% |
Future return on equity | 5.7% |
Analyst coverage | Low |
Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,855 | 49 | 140 | 412 | 4 |
12/31/2025 | 2,708 | -12 | 128 | 350 | 5 |
12/31/2024 | 2,662 | -125 | 123 | 365 | 5 |
9/30/2024 | 2,614 | -636 | 223 | 386 | N/A |
6/30/2024 | 2,582 | -616 | 199 | 392 | N/A |
3/31/2024 | 2,556 | -601 | 112 | 329 | N/A |
12/31/2023 | 2,521 | -649 | -108 | 160 | N/A |
9/30/2023 | 2,461 | -279 | -384 | -17 | N/A |
6/30/2023 | 2,522 | -240 | -534 | -88 | N/A |
3/31/2023 | 2,574 | -177 | -772 | -171 | N/A |
12/31/2022 | 2,566 | -73 | -742 | -43 | N/A |
9/30/2022 | 2,576 | 68 | -624 | 121 | N/A |
6/30/2022 | 2,455 | 92 | -598 | 209 | N/A |
3/31/2022 | 2,320 | 105 | -453 | 362 | N/A |
12/31/2021 | 2,195 | 110 | -450 | 394 | N/A |
9/30/2021 | 2,026 | 109 | -479 | 371 | N/A |
6/30/2021 | 1,856 | 86 | -560 | 266 | N/A |
3/31/2021 | 1,656 | 12 | -613 | 129 | N/A |
12/31/2020 | 1,633 | 6 | -620 | 49 | N/A |
9/30/2020 | 1,702 | 3 | -474 | 60 | N/A |
6/30/2020 | 1,860 | 46 | -314 | 103 | N/A |
3/31/2020 | 2,058 | 101 | -134 | 203 | N/A |
12/31/2019 | 2,162 | 123 | 1 | 245 | N/A |
9/30/2019 | 2,210 | 132 | -39 | 204 | N/A |
6/30/2019 | 2,240 | 136 | 11 | 246 | N/A |
3/31/2019 | 2,236 | 143 | 1 | 245 | N/A |
12/31/2018 | 2,232 | 149 | 22 | 280 | N/A |
9/30/2018 | 2,222 | 197 | -29 | 256 | N/A |
6/30/2018 | 2,240 | 222 | N/A | 228 | N/A |
3/31/2018 | 2,275 | 255 | N/A | 274 | N/A |
12/31/2017 | 2,305 | 278 | N/A | 271 | N/A |
9/30/2017 | 2,318 | 282 | N/A | 361 | N/A |
6/30/2017 | 2,278 | 280 | N/A | 406 | N/A |
3/31/2017 | 2,232 | 255 | N/A | 475 | N/A |
12/31/2016 | 2,156 | 225 | N/A | 473 | N/A |
9/30/2016 | 2,123 | 200 | N/A | 405 | N/A |
6/30/2016 | 2,084 | 167 | N/A | 385 | N/A |
3/31/2016 | 2,044 | 153 | N/A | 282 | N/A |
12/31/2015 | 2,006 | 127 | N/A | 216 | N/A |
9/30/2015 | 1,991 | 28 | N/A | 245 | N/A |
6/30/2015 | 1,944 | 24 | N/A | 215 | N/A |
3/31/2015 | 1,915 | -3 | N/A | 214 | N/A |
12/31/2014 | 1,899 | -13 | N/A | 219 | N/A |
9/30/2014 | 1,895 | 11 | N/A | 184 | N/A |
6/30/2014 | 1,901 | 2 | N/A | 139 | N/A |
3/31/2014 | 1,924 | 18 | N/A | 127 | N/A |
12/31/2013 | 1,948 | 31 | N/A | 82 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0NCV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: 0NCV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0NCV is expected to become profitable in the next 3 years.
Revenue vs Market: 0NCV's revenue (2.8% per year) is forecast to grow slower than the UK market (3.5% per year).
High Growth Revenue: 0NCV's revenue (2.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0NCV's Return on Equity is forecast to be low in 3 years time (5.7%).